63
Participants
Start Date
November 30, 2023
Primary Completion Date
November 30, 2025
Study Completion Date
November 30, 2026
simultaneous with radiotherapy
Chemotherapy combined with immunotherapy simultaneous with radiotherapy
synchronous with radiotherapy
Chemotherapy combined with immunotherapy synchronous with radiotherapy
West China Hospital
OTHER